AI is neither poison nor panacea for doctors
AI in Medicine Needs Guardrails, Not Hype
Indiadailyupdate.com – Artificial intelligence is rapidly becoming an unseen participant in the relationship between doctors and patients. A clinician may use a digital tool to check whether prescribed medicines could clash or whether an important possibility has been overlooked. Later, the patient may turn to another AI system to question the diagnosis or the need for treatment. Neither may know the other has sought that additional input.
In principle, an extra opinion can be helpful. The harder questions arise when the machine’s recommendation conflicts with a doctor’s judgement, or when two AI tools offer competing answers. If a patient suffers because of that advice, responsibility cannot remain vague. These are not merely technology questions; they go to the heart of trust, accountability and safe medical care.
Ability is not the same as readiness
There is growing evidence that autonomous systems could eventually exceed doctors in selected thinking-intensive tasks. An expert article in JAMA envisages a future in which AI may perform better than clinicians in certain cognitive areas. A 2026 Nature study examined MIRA, an autonomous system tested on simulated electronic health records. Across 311 cases, its diagnostic accuracy was 87.8%, compared with 78.1% for physicians.
Those results show meaningful potential, but they do not establish that independent AI is ready to take over ordinary clinical decision-making. A diagnosis is only one component of treatment. Patients can have several conditions at once, may be taking medicines that affect one another, and may face personal, financial or practical constraints that cannot be reduced to a prediction score.
A medically plausible recommendation also has to fit the individual receiving it. Treatment may be unaffordable, difficult to tolerate, inconsistent with a patient’s priorities or simply unwanted. No automated diagnosis can settle those questions on its own.
A practical path: controlled autonomy
The more realistic near-term approach is limited AI autonomy within boundaries established by clinicians. In 2025, the US Food and Drug Administration cleared UpDoc, a system that gives insulin-dose instructions to adults with type-2 diabetes. Doctors define the targets and limits for its use. The system can also decline to provide guidance or advise users to seek further help when circumstances require it.
This kind of design recognises that not every task carries the same degree of risk. Routine administrative work and tightly defined support functions may be suitable for automation earlier than complex clinical decisions. But simply placing a doctor somewhere in the workflow does not automatically guarantee better outcomes.
An analysis covering 52 studies found that clinicians assisted by AI improved performance by seven percentage points over clinicians working alone. Yet fewer than half of human-AI combinations outperformed both the doctor and the AI operating independently. In some cases, the partnership performed worse. A 2026 trial in Kenya likewise found better diagnoses with AI support, but no statistically significant fall in treatment failure.
These findings underline a basic lesson: accurate identification of a condition is valuable, but it is not the same as successful care. Health outcomes depend on follow-up, medicines, access, adherence, complications and the realities of each person’s life.
Efficiency may create new demands
There is another tension in the promise of automation. Dhruv Khullar has raised in The New England Journal of Medicine the question of whether AI-driven efficiency could shrink the need for health workers. The answer is unlikely to be straightforward. A system that completes some tasks faster may also identify more abnormalities, trigger more tests and generate additional follow-up needs.
Technology could shorten one part of the clinical process while expanding the overall amount of care required. This makes it risky to view AI as a simple substitute for medical professionals. Even where machines help identify patterns or summarise information, people are still needed to explain uncertainty, weigh trade-offs and make decisions with patients rather than merely for them.
“Technological solutionism” can overstate what AI can safely and usefully accomplish.
India must avoid a two-tier AI future
For India, health-care AI could have important practical uses. It may help explain health information in languages people know well, support monitoring of glucose or blood pressure, reduce documentation burdens and strengthen primary care in areas where specialists are limited. These applications could make professional attention more available rather than less personal.
However, AI must not become a lower-cost substitute for doctor-led care only for people who cannot afford to see a clinician. The World Health Organization has cautioned against technological solutionism: the tendency to place excessive faith in a tool while neglecting safety, effectiveness and real-world usefulness.
Systems tested in other countries may not work equally well in Indian settings. Differences in patients, disease patterns, language, health infrastructure and access to treatment matter. Tools should therefore be evaluated and audited within Indian patient populations before their clinical role is widened.
A graded model offers a sensible direction. Low-risk administrative functions can be automated first. More consequential clinical tasks should be introduced only after careful testing, oversight and continuing review. Strong data protection is essential, as is a clear framework for accountability when systems fail or their recommendations cause harm.
The doctor’s role will become more important, not less human
Doctors will need the ability to challenge AI rather than either rejecting it reflexively or accepting it without scrutiny. Experienced clinicians may be tempted to dismiss a machine’s input. Less experienced doctors, especially those without strong educational and practical foundations, may place too much confidence in it.
Clinicians cannot realistically compete with computers on sheer recall of medical facts. Their distinctive contribution is different: recognising when a system may be mistaken, interpreting data within a patient’s wider circumstances, and translating information into care that can be understood, afforded and accepted.
AI will undoubtedly take over some medical tasks. Its value should be judged not by how impressive its recommendations appear, but by whether patients ultimately receive safer, more appropriate and more effective care. A recommendation can be technically correct and still be the wrong answer for the person sitting in front of the doctor.
Related Reading
Frequently Asked Questions
What is AI is neither poison nor panacea?AI is neither poison nor panacea is the main topic of this guide. The article explains the context, practical details, and next steps readers should understand.
Why does AI is neither poison nor panacea matter?AI is neither poison nor panacea matters because readers are looking for a useful answer, not just a short summary. Good content should match search intent and help them decide what to do next.